Retrospective study of urinalysis for dl-amphetamine and dl-methamphetamine analysis under current Department of Defense guidelines.
Under current Department of Defense (DOD) directive, the laboratories certified to conduct urinalyis testing in support of the DOD Drug Deterrence Program are required to conduct dl-isomer analysis on all specimens that confirm at a concentration greater than 500 ng/mL methamphetamine (METH). Although the same cutoff concentration is required for amphetamine (AMP) reporting, there is no requirement for dl-isomer analysis of AMP-positive specimens. Of the 894,823 specimens screened by the Army Drug Testing Laboratory at Ft. Meade, MD during a 19-month period, 339 confirmed positive for METH. From this positive population, seven specimens failed to confirm at or above the DOD cutoff of > 20% d-isomer. One of the seven specimens contained 534 ng/mL l-AMP and was reported positive for AMP. Although 100% of the AMP was the l-isomer, under current DOD directive, this information was not passed along to the Medical Review Officers (MRO) to assist them during the interview process. Although this situation appears to be a rare event, consideration should be given to requiring dl-isomer analysis of AMP-positive specimens and forwarding this information to the MRO.
Shippee
R L
RL
U.S. Army Forensic Toxicology Drug Testing Laboratory, Fort Meade, Maryland 20755, USA.
Kippenberger
D J
DJ
D000661:Amphetamine / Q000652:urine*; D006077:Government Agencies; D017408:Guidelines as Topic; D006801:Humans; D008694:Methamphetamine / Q000652:urine*; D012189:Retrospective Studies; D015813:Substance Abuse Detection / Q000379:methods*
D008694:Methamphetamine; D000661:Amphetamine